Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-06 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.640 | ||||||
REV | 64.998M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
FGEN | FibroGen | 19.26 | -0.47 | -2.38% | 1.8B |
You can purchase shares of FibroGen (NASDAQ: FGEN) through any online brokerage.
Other companies in FibroGen’s space includes: Zentalis Pharmaceuticals (NASDAQ:ZNTL), Cerevel Therapeutics Hldg (NASDAQ:CERE) and ADC Therapeutics (NYSE:ADCT).
The latest price target for FibroGen (NASDAQ: FGEN) was reported by Mizuho on 2021-04-07. The analyst firm set a price target for 29.00 expecting FGEN to rise to within 12 months (a possible 50.57% upside). 15 analyst firms have reported ratings in the last year.
The stock price for FibroGen (NASDAQ: FGEN) is $19.26 last updated Wed Apr 14 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for FibroGen.
There is no upcoming split for FibroGen.